Nuzenio

Arcus Biosciences Inc

Arcus Biosciences Inc news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 05:10:00 GMTArcus Biosciences (RCUS) Stock Gets Fair Value Bump After Casdatifan Optimism - Yahoo Finance
Fri, 07 Aug 2026 20:31:22 GMTArcus Biosciences (NYSE: RCUS) gets 24.7% ownership from Gilead - Stock Titan
Fri, 07 Aug 2026 09:26:20 GMTArcus Biosciences Inc (RCUS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Thu, 06 Aug 2026 18:32:26 GMTArcus Biosciences (NYSE:RCUS) Price Target Raised to $26.00 - MarketBeat
Thu, 06 Aug 2026 18:27:16 GMTRCUS Maintained by Wedbush -- Price Target Raised to $43.00 - GuruFocus
Thu, 06 Aug 2026 17:20:44 GMTArcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.25, Implies 38% Upside - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Arcus Biosciences Inc.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.